Second quarter earnings season is upon us and Cowen & Co. is counting on the biotechnology sector to deliver.
Last week, Piper Jaffray’s analyst team recommended several favorite stocks across many sectors to consider in the second half of 2015. The firm …
In a research report published today, Piper Jaffray analyst Joshua Schimmer offered some favorable commentary on GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) after attending a one-day course at …
GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced that …
GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) ), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced …
GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announces that …
GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announces financial …
GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, …
GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced …
GW Pharmaceuticals plc (NASDAQ:GWPH), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced today …
